Tissue polypeptide antigen (TPA) is the primary agent for developing a vaccine against coronavirus, and Shanghai's GL Biochem company is busy producing the element. 40 of their labs are currently functioning, and 500 workers have successfully produced 3500 TPAs in just three weeks. These TPAs will be used in vaccine development and related scientific experiments globally. (Photos: Yang Hui/GT)